6 ways starting a GLP-1 medication could affect your emotions
UC obesity medicine expert shares insights
When patients first start taking a glucagon-like peptide-1 (GLP-1) medication, they probably expect to feel full. But as Everyday Health recently reported, they might not anticipate how it can influence their emotions.
“These medications don’t just act on your stomach,” said Malti Vij, MD, a University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine and a diplomate of the American Board of Obesity Medicine. “They also act on the brain.”
Research suggests that GLP-1s act on satiety centers in the brain, which control hunger and eating behavior, and on reward centers, which affect pleasure and the motivation to engage in enjoyable activities.
By reducing reward-seeking behavior, GLP-1s might curb more than overeating. Emerging research suggests these medications could also help people cut back on drinking, smoking and illicit drug use.
The direct effect of GLP-1s on the brain can partially explain their emotional impact. Weight loss itself, which can become noticeable in a matter of weeks, can also affect a person's emotions.
Here are six ways starting a GLP-1 medication could affect a person's emotions:
1. You may feel more grateful
2. Your sex life may improve
3. You may have better impulse control
4. Your mood may improve
5. You may feel more hopeful about your future
6. You may feel a stronger sense of belonging
Read the complete Everyday Health article for an explanation of each of the six ways.
Featured image at top: Weight loss drug injection pens and a measuring tape. Photo/iStock/Alones Creative.
Related Stories
Phenols, found in many products, could upset heart's rhythms
October 7, 2024
Chemicals called environmental phenols include food preservatives, plastics ingredients such as BPA and the parabens in shampoos, so they are ubiquitous in everyday life. Now, University of Cincinnati research suggests that higher exposure to phenols might trigger changes in the heart's electrical system and rhythms.
Researchers work to make blood cancer a manageable disease
September 17, 2025
During Blood Cancer Awareness Month, Spectrum News and MSN highlighted researchers in the University of Cincinnati Cancer Center’s Leukemia and Drug Development Lab working to make blood cancer a manageable illness and bring new treatments to patients more efficiently than ever before.
Nephrologists miss opportunities to discuss contraceptive use with women with chronic kidney disease
November 7, 2025
Discussions about contraceptive use for women with chronic kidney disease are often avoided by nephrologists, according to University of Cincinnati data presented this week at the American Society of Nephrology's Kidney Week global. meeting in Houston. Nephrologists reported that they see the importance of reproductive health but feel ill-equipped to discuss it with patients. Discomfort, limited training and confusing guidance were among the key barriers to discussions.